Gemina Laboratories Ltd.
GLABF
$0.528
-$0.0839-13.71%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.93% | 11.07% | -16.31% | -7.80% | 34.41% |
| Total Depreciation and Amortization | -1.85% | 10.20% | -1.01% | 0.51% | -2.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.83% | -31.38% | 49.75% | 162.92% | -141.86% |
| Change in Net Operating Assets | 90.63% | 9.98% | 529.01% | -112.42% | 101.07% |
| Cash from Operations | 80.47% | 37.92% | 64.95% | -9,819.67% | 103.03% |
| Capital Expenditure | -- | -- | -- | -- | 234.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 234.83% |
| Total Debt Issued | -100.00% | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | 0.95% | -16.67% | 2.53% | -4.92% | 2.22% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | 100.00% | -- | -- |
| Cash from Financing | -308.86% | -97.79% | -39.72% | 3,127.55% | -115.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.20% | -180.77% | 29,860.00% | 135.71% | 98.31% |